# Effects of Different Antirheumatic Treatments of Arthritis on Antibody Response Following Vaccination Using Prevenar®

> **NCT00828997** · PHASE4 · COMPLETED · sponsor: **Region Skane** · enrollment: 505 (actual)

## Conditions studied

- Rheumatoid Arthritis
- Spondylarthropathy

## Interventions

- **BIOLOGICAL:** Prevenar vaccination

## Key facts

- **NCT ID:** NCT00828997
- **Lead sponsor:** Region Skane
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2018-01
- **Final completion:** 2018-01
- **Target enrollment:** 505 (ACTUAL)
- **Last updated:** 2018-12-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00828997

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00828997, "Effects of Different Antirheumatic Treatments of Arthritis on Antibody Response Following Vaccination Using Prevenar®". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00828997. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*